CD Diagnostics' Seed Round

CD Diagnostics raised a round of funding on January 16, 2012. Investors include Ben Franklin Technology Partners of Southeastern PA.

CD Diagnostics is developing assays for orthopaedic surgeons and rheumatologists for joint fluid analysis. The company's lead product, CygnaSure, offers orthopaedic surgeons and rheumatologists a rapi…

Articles about CD Diagnostics' Seed Round: